115 related articles for article (PubMed ID: 34841595)
21. Molecular subtyping predicts pathologic tumor response in early-stage breast cancer treated with neoadjuvant docetaxel plus capecitabine with or without trastuzumab chemotherapy.
Bayraktar S; Royce M; Stork-Sloots L; de Snoo F; Glück S
Med Oncol; 2014 Oct; 31(10):163. PubMed ID: 25186065
[TBL] [Abstract][Full Text] [Related]
22. Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).
Whitworth P; Stork-Sloots L; de Snoo FA; Richards P; Rotkis M; Beatty J; Mislowsky A; Pellicane JV; Nguyen B; Lee L; Nash C; Gittleman M; Akbari S; Beitsch PD
Ann Surg Oncol; 2014 Oct; 21(10):3261-7. PubMed ID: 25099655
[TBL] [Abstract][Full Text] [Related]
23. Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups.
Yao K; Goldschmidt R; Turk M; Wesseling J; Stork-Sloots L; de Snoo F; Cristofanilli M
Breast Cancer Res Treat; 2015 Nov; 154(1):81-8. PubMed ID: 26424167
[TBL] [Abstract][Full Text] [Related]
24. 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Piccart M; van 't Veer LJ; Poncet C; Lopes Cardozo JMN; Delaloge S; Pierga JY; Vuylsteke P; Brain E; Vrijaldenhoven S; Neijenhuis PA; Causeret S; Smilde TJ; Viale G; Glas AM; Delorenzi M; Sotiriou C; Rubio IT; Kümmel S; Zoppoli G; Thompson AM; Matos E; Zaman K; Hilbers F; Fumagalli D; Ravdin P; Knox S; Tryfonidis K; Peric A; Meulemans B; Bogaerts J; Cardoso F; Rutgers EJT
Lancet Oncol; 2021 Apr; 22(4):476-488. PubMed ID: 33721561
[TBL] [Abstract][Full Text] [Related]
25. Exogenous Fatty Acids Modulate ER Lipid Composition and Metabolism in Breast Cancer Cells.
Rizzo AM; Colombo I; Montorfano G; Zava S; Corsetto PA
Cells; 2021 Jan; 10(1):. PubMed ID: 33467111
[TBL] [Abstract][Full Text] [Related]
26. Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer.
Hong Z; Wang Q; Hong C; Liu M; Qiu P; Lin R; Lin X; Chen F; Li Q; Liu L; Wang C; Chen D
J Cancer; 2021; 12(3):740-753. PubMed ID: 33403032
[TBL] [Abstract][Full Text] [Related]
27. MELK/MPK38 in cancer: from mechanistic aspects to therapeutic strategies.
Thangaraj K; Ponnusamy L; Natarajan SR; Manoharan R
Drug Discov Today; 2020 Dec; 25(12):2161-2173. PubMed ID: 33010478
[TBL] [Abstract][Full Text] [Related]
28. Effects of germline and somatic events in candidate BRCA-like genes on breast-tumor signatures.
Bodily WR; Shirts BH; Walsh T; Gulsuner S; King MC; Parker A; Roosan M; Piccolo SR
PLoS One; 2020; 15(9):e0239197. PubMed ID: 32997669
[TBL] [Abstract][Full Text] [Related]
29. RNA-sequencing and microarray data mining revealing: the aberrantly expressed mRNAs were related with a poor outcome in the triple negative breast cancer patients.
Fei H; Chen S; Xu C
Ann Transl Med; 2020 Mar; 8(6):363. PubMed ID: 32355807
[TBL] [Abstract][Full Text] [Related]
30. Enigmatic MELK: The controversy surrounding its complex role in cancer.
McDonald IM; Graves LM
J Biol Chem; 2020 Jun; 295(24):8195-8203. PubMed ID: 32350113
[TBL] [Abstract][Full Text] [Related]
31. Performance Characteristics of the BluePrint® Breast Cancer Diagnostic Test.
Mittempergher L; Delahaye LJ; Witteveen AT; Snel MH; Mee S; Chan BY; Dreezen C; Besseling N; Luiten EJ;
Transl Oncol; 2020 Apr; 13(4):100756. PubMed ID: 32208353
[TBL] [Abstract][Full Text] [Related]
32. MIR210HG promotes cell proliferation and invasion by regulating miR-503-5p/TRAF4 axis in cervical cancer.
Wang AH; Jin CH; Cui GY; Li HY; Wang Y; Yu JJ; Wang RF; Tian XY
Aging (Albany NY); 2020 Feb; 12(4):3205-3217. PubMed ID: 32087604
[TBL] [Abstract][Full Text] [Related]
33. Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1.
Bollu LR; Shepherd J; Zhao D; Ma Y; Tahaney W; Speers C; Mazumdar A; Mills GB; Brown PH
NPJ Breast Cancer; 2020; 6():2. PubMed ID: 31909186
[TBL] [Abstract][Full Text] [Related]
34. Mass spectrometry-based selectivity profiling identifies a highly selective inhibitor of the kinase MELK that delays mitotic entry in cancer cells.
McDonald IM; Grant GD; East MP; Gilbert TSK; Wilkerson EM; Goldfarb D; Beri J; Herring LE; Vaziri C; Cook JG; Emanuele MJ; Graves LM
J Biol Chem; 2020 Feb; 295(8):2359-2374. PubMed ID: 31896573
[TBL] [Abstract][Full Text] [Related]
35. CCDC74A/B are K-fiber crosslinkers required for chromosomal alignment.
Zhou H; Zheng T; Wang T; Li Q; Wang F; Liang X; Chen J; Teng J
BMC Biol; 2019 Sep; 17(1):73. PubMed ID: 31521166
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology.
Sturm G; Finotello F; Petitprez F; Zhang JD; Baumbach J; Fridman WH; List M; Aneichyk T
Bioinformatics; 2019 Jul; 35(14):i436-i445. PubMed ID: 31510660
[TBL] [Abstract][Full Text] [Related]
37. Integral analyses of survival-related long non-coding RNA MIR210HG and its prognostic role in colon cancer.
Ruan Z; Xu Z; Li Z; Lv Y
Oncol Lett; 2019 Aug; 18(2):1107-1116. PubMed ID: 31423171
[TBL] [Abstract][Full Text] [Related]
38. The long noncoding RNA MIR210HG promotes tumor metastasis by acting as a ceRNA of miR-1226-3p to regulate mucin-1c expression in invasive breast cancer.
Li XY; Zhou LY; Luo H; Zhu Q; Zuo L; Liu GY; Feng C; Zhao JY; Zhang YY; Li X
Aging (Albany NY); 2019 Aug; 11(15):5646-5665. PubMed ID: 31399552
[TBL] [Abstract][Full Text] [Related]
39. Relation of
Huang D; Huang Y; Huang Z; Weng J; Zhang S; Gu W
Cancer Cell Int; 2019; 19():166. PubMed ID: 31244554
[TBL] [Abstract][Full Text] [Related]
40. LncRNA MIR210HG promotes proliferation and invasion of non-small cell lung cancer by upregulating methylation of CACNA2D2 promoter via binding to DNMT1.
Kang X; Kong F; Huang K; Li L; Li Z; Wang X; Zhang W; Wu X
Onco Targets Ther; 2019; 12():3779-3790. PubMed ID: 31190878
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
